Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advanced ovarian cancer.

D S Chi1, P Sabbatini

  • 1Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

Current Treatment Options in Oncology
|June 12, 2002
PubMed
Summary

Advanced ovarian cancer treatment involves surgery and chemotherapy, but recurrence is common. Novel consolidation strategies are needed to improve long-term disease-free survival for patients after initial therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant transformation of a solitary osteochondroma to chondrosarcoma in a cat.

Australian veterinary journal·2026
Same author

Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.

Gynecologic oncology·2017
Same author

Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.

European radiology·2015
Same author

Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?

Gynecologic oncology·2013
Same author

Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.

Gynecologic oncology·2012

Area of Science:

  • Gynecologic Oncology
  • Medical Oncology
  • Surgical Oncology

Background:

  • Advanced ovarian cancer necessitates a multimodality treatment approach, beginning with aggressive surgical debulking.
  • Standard primary treatment involves paclitaxel and carboplatin chemotherapy, achieving remission in about 70% of patients, but with a high rate of relapse.

Purpose of the Study:

  • To review current treatment strategies for advanced ovarian cancer, including primary therapy and management of recurrent disease.
  • To highlight the need for novel consolidation strategies to improve outcomes following initial treatment.

Main Methods:

  • Review of state-of-the-art treatment protocols for advanced ovarian cancer.
  • Discussion of surgical interventions, including primary cytoreductive surgery and second-look laparoscopy.
  • Analysis of systemic and intraperitoneal chemotherapy options for consolidation and recurrent disease management.

Main Results:

  • While primary chemotherapy yields high initial remission rates, less than 30% of patients remain disease-free.
  • Second-look surgery accurately identifies persistent microscopic disease, but relapse risk remains even after negative pathology.
  • No standard consolidation therapy exists post-primary treatment, and most patients eventually relapse.

Conclusions:

  • Effective management of advanced ovarian cancer requires optimizing primary treatment and developing novel consolidation strategies.
  • Treatment for recurrent ovarian cancer depends on factors like treatment-free interval and drug resistance.
  • Further research into innovative therapies is crucial to improve long-term survival for ovarian cancer patients.

Related Experiment Videos